Thomas M. Munger, M.D.

Closed for Enrollment

• Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO) (ASAP-TOO) Rochester, Minn.

  The purpose of this study is to establish the safety and effectiveness of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device, including the post-implant medication regimen, for subjects with non-valvular atrial fibrillation who are deemed not to be eligible for anti-coagulation therapy to reduce the risk of stroke.

• Prospective Registry on User Experience With The Mapping System For Ablation Procedures (TRUE-HD) Rochester, Minn.

  This is an observational, prospective, non-randomized, multicenter, post approval study being conducted in the United States, Europe and Asia-Pacific Regions.